---
figid: PMC5452883__ol-13-06-4047-g00
figtitle: Intratumoral synthesis of E2 and its inactivation by sulfate conjugation
  from circulating steroid hormone precursors in cancer cells
organisms:
- Homo sapiens
- Mus musculus
organisms_ner:
- Homo sapiens
- Mus musculus
- Danio rerio
pmcid: PMC5452883
filename: ol-13-06-4047-g00.jpg
figlink: /pmc/articles/PMC5452883/figure/f1-ol-0-0-5969/
number: F1
caption: Intratumoral synthesis of E2 and its inactivation by sulfate conjugation
  from circulating steroid hormone precursors in cancer cells. E2 is synthesized from
  E1S in the sulfatase pathway, and from DHEA-S in the aromatase pathway. E1S and
  DHEA-S are taken up from the circulation by transporters, such as those from the
  OATP family encoded by SCLO. In the sulfatase pathway, HSD-17β1 generates E2 from
  E1S, while E1 and E2 are inactivated by sulfonation by SULT1E1. Sulfonated estrogens
  do not bind to the ERα or ERβ. Aromatase generates E2 from androgenic precursors
  via the aromatase pathway. E2, 17β-estradiol; -S, sulfate; E1, estrone; STS, steroid
  sulfatase; SULT1E1, estrogen sulfotransferase; ER, estrogen receptor; DHEA, dehydroepiandrosterone
  sulfate; HSD-17β, 17β-hydroxysteroid dehydrogenase; OATP, organic anion transporting
  polypeptides; SLCO, solute carrier for organic anions.
papertitle: Clinical significance of the estrogen-modifying enzymes steroid sulfatase
  and estrogen sulfotransferase in epithelial ovarian cancer.
reftext: Felicitas Mungenast, et al. Oncol Lett. 2017 Jun;13(6):4047-4054.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.883913
figid_alias: PMC5452883__F1
figtype: Figure
redirect_from: /figures/PMC5452883__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5452883__ol-13-06-4047-g00.html
  '@type': Dataset
  description: Intratumoral synthesis of E2 and its inactivation by sulfate conjugation
    from circulating steroid hormone precursors in cancer cells. E2 is synthesized
    from E1S in the sulfatase pathway, and from DHEA-S in the aromatase pathway. E1S
    and DHEA-S are taken up from the circulation by transporters, such as those from
    the OATP family encoded by SCLO. In the sulfatase pathway, HSD-17β1 generates
    E2 from E1S, while E1 and E2 are inactivated by sulfonation by SULT1E1. Sulfonated
    estrogens do not bind to the ERα or ERβ. Aromatase generates E2 from androgenic
    precursors via the aromatase pathway. E2, 17β-estradiol; -S, sulfate; E1, estrone;
    STS, steroid sulfatase; SULT1E1, estrogen sulfotransferase; ER, estrogen receptor;
    DHEA, dehydroepiandrosterone sulfate; HSD-17β, 17β-hydroxysteroid dehydrogenase;
    OATP, organic anion transporting polypeptides; SLCO, solute carrier for organic
    anions.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ARSH
  - SULT1E1
  - ESR1
  - ERAL1
  - ESR2
  - HSD17B2
  - HSD17B7P2
  - HSD17B1
  - STS
  - SULT2A1
  - SLCO1A2
  - Sult1e1
  - Esr1
  - Eral1
  - Esr2
  - Hsd17b2
  - Hsd17b1
  - Sts
  - esr1
  - hsd17b2
  - hsd17b1
  - sts
  - DHEA
  - Testosterone
wpid: WP5368
---
